- Home
- ENSC vs AMIX Comparison
ENSC vs AMIX Comparison
Compare ENSC & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- AMIX
- Stock Information
- Founded
- ENSC 2003
- AMIX 2014
- Country
- ENSC United States
- AMIX United States
- Employees
- ENSC N/A
- AMIX N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- ENSC Health Care
- AMIX
- Exchange
- ENSC Nasdaq
- AMIX NYSE
- Market Cap
- ENSC 5.5M
- AMIX 5.5M
- IPO Year
- ENSC N/A
- AMIX N/A
- Fundamental
- Price
- ENSC $2.64
- AMIX $1.74
- Analyst Decision
- ENSC
- AMIX
- Analyst Count
- ENSC 0
- AMIX 0
- Target Price
- ENSC N/A
- AMIX N/A
- AVG Volume (30 Days)
- ENSC 24.9K
- AMIX 41.8K
- Earning Date
- ENSC 05-12-2025
- AMIX 02-13-2025
- Dividend Yield
- ENSC N/A
- AMIX N/A
- EPS Growth
- ENSC N/A
- AMIX N/A
- EPS
- ENSC N/A
- AMIX N/A
- Revenue
- ENSC $5,210,031.00
- AMIX N/A
- Revenue This Year
- ENSC N/A
- AMIX N/A
- Revenue Next Year
- ENSC N/A
- AMIX N/A
- P/E Ratio
- ENSC N/A
- AMIX N/A
- Revenue Growth
- ENSC 133.58
- AMIX N/A
- 52 Week Low
- ENSC $2.12
- AMIX $1.52
- 52 Week High
- ENSC $14.67
- AMIX $75.80
- Technical
- Relative Strength Index (RSI)
- ENSC 23.45
- AMIX 33.31
- Support Level
- ENSC $3.30
- AMIX $1.69
- Resistance Level
- ENSC $3.58
- AMIX $2.11
- Average True Range (ATR)
- ENSC 0.32
- AMIX 0.17
- MACD
- ENSC -0.05
- AMIX -0.00
- Stochastic Oscillator
- ENSC 22.21
- AMIX 30.13
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.